| | | |   | | | | By Jason Mast Go Nakamura/Getty Images Studies of treatments for hospitalized Covid patients are becoming harder to conduct, even as 2,000 people continue to die daily worldwide. Read More | | By Ed Silverman Mark Lennihan/AP A controversial group has sued Pfizer over a fellowship to boost diversity. Legal experts say the case is "desperate and likely futile." Read More | | By Isabella Cueto OSCAR DEL POZO/AFP via Getty Images Federal health officials want to see if paying dialysis providers differently will encourage more home use and more organ transplants. Read More | | Sponsor content by Alexion Pharmaceuticals Advancing rare disease drug development requires unique solutions One in ten Americans suffers from a rare disease, and only 5% of the estimated 7,000 to 10,000 known rare diseases have an FDA-approved treatment. Addressing regulatory barriers could change that. Cross-agency coordination at the federal level, cross-center coordination at FDA, and increased engagement with patients have the potential to help bring new treatments to 30 million rare disease patients sooner. Learn more about what makes rare diseases unique here. | | By Ambar Castillo MW Concepts Photography/STAT Rep. Robin Kelly admits that the word "diversity" has scared some Republicans away from improving representation in clinical trials. Read More | |
No comments